Spyre Therapeutics, Inc.

NASDAQ
SYRE
Stock
Yield per half year: -23.66%
Dividend yield: 0%
Sector: Healthcare

Reporting Spyre Therapeutics, Inc.

Capitalization

IFRS
Reporting Annual Quarterly
2016 2017 2018 2019 2020 2021 2022 2023 2024 LTM 5 year average CAGR 5
Капитализация, млрд $
0.0063 0.005 0.0087 0.0077 0.0151 0.0139 0.0039 0.0708 0.0223 55.85
Выручка, млрд $
0.0046 0.0052 0.0039 0.0187 0.0023 0.000886 0.000886 0.000886 0.0053 -25.65
Чистая прибыль, млрд $
-0.0217 -0.0272 -0.0443 -0.0832 -0.0809 -0.0658 -0.0838 -0.3388 -0.208 -0.208 -0.1555 20.79
EV, млрд $
0.2316 0.3354 0.3022 0.0000 0.021 8.35 8.35 1.85 104.83
EBIT, млрд $
-0.0219 -0.0277 -0.0455 -0.0803 -0.0815 -0.0656 -0.0852 -0.243 -0.1288 -0.1288 -0.1208 9.59
EBITDA, млрд $
-0.0218 -0.0274 -0.0452 -0.0794 -0.0805 -0.0641 -0.0832 -0.2423 -0.208 -0.208 -0.1356 20.91
OIBDA, млрд $
-0.0799 -0.0635 -0.0842 -0.1458 -0.2085 -0.2085 -0.1164 21.15
Баланс стоимость, млрд $
0.063 0.0503 0.0674 0.0601 0.1398 0.0839 0.0503 0.184 0.5178 0.5178 0.1952 29.94
FCF, млрд $
-0.0191 -0.0252 -0.0326 -0.0786 -0.0801 -0.0543 -0.0802 -0.0999 -0.1574 -0.1574 -0.0944 14.47
Операционный денежный поток, млрд $
-0.0188 -0.0246 -0.0322 -0.0746 -0.0758 -0.0537 -0.0801 -0.0999 -0.1574 -0.1574 -0.0934 15.74
Операционная прибыль, млрд $
-0.0219 -0.0277 -0.0455 -0.0846 -0.0815 -0.0656 -0.0848 -0.2423 -0.2086 -0.2086 -0.1366 20.68
Операционные расходы, млрд $
0.0264 0.0326 0.0491 0.0846 0.0815 0.0844 0.0871 0.2432 0.2086 0.2086 0.1410 20.68
CAPEX, млрд $
0.000212 0.000619 0.000422 0.004 0.0043 0.000573 0.0000 0.0020 -1.53


Balance sheet

IFRS
Reporting Annual Quarterly
2016 2017 2018 2019 2020 2021 2022 2023 2024 LTM 5 year average CAGR 5
Наличность, млрд $
0.0477 0.0128 0.0225 0.0193 0.0901 0.0151 0.0349 0.1889 0.0894 0.0894 0.0837 -0.16
Short Term Investments $
0.0158 0.0375 0.0521 0.0527 0.0562 0.078 0.0208 0.1504 0.5137 0.5137 0.1638 55.67
Total Receivables $
0.0012 0.0031 0.0003 0.000815 0.000375 0.0012 -20.76
Total Current Assets $
0.0664 0.055 0.0767 0.0745 0.1498 0.0989 0.0623 0.3415 0.6085 0.6085 0.2522 32.36
Активы, млрд $
0.0671 0.0561 0.0777 0.0832 0.1616 0.1099 0.0711 0.3419 0.6085 0.6085 0.2586 30.37
Short Term Debt $
0.000379 0.000319 0.000436 0.000625 0.0004 13.32
Задолженность, млрд $
0.0041 0.0057 0.0103 0.0231 0.0218 0.026 0.0208 0.1578 0.0907 0.0907 0.0634 32.99
Чистый долг, млрд $
-0.0477 -0.0128 -0.0225 -0.0141 -0.0846 -0.0101 -0.0302 -0.1043 -0.0894 -0.0894 -0.0637 1.11
Долг, млрд $
0.0051 0.0054 0.0051 0.0046 0.0846 0.0846 0.0846 0.0369 73.38
Interest income $
0.0015 0.000593 0.000111 0.000837 0.0061 0.0018 32.39
Чист. проц. доходы, млрд $
0.0015 0.000593 0.000111 0.000837 0.0061 0.0061 0.0018 32.39
Амортизация, млрд $
0.000132 0.000249 0.000293 0.000901 0.000996 0.0016 0.002 0.000744 0.000964 0.000964 0.0013 -0.65
Себестоимость, млрд $
0.000901 0.0016 0.002 0.002 0.000964 0.000964 0.000964 0.0015 -9.64


Share

IFRS
Reporting Annual Quarterly
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 LTM 5 year average CAGR 5
EPS -178.91 -11.17 -52.75 -71.53 -42.17 -33.33 -24.86 -49.12 -0.5556 -0.5556 -30.0071 -57.93
Цена акции ао 4.95 8.74 7.72 7.53 7.05 1.48 21.52 23.28 17.29 17.29 14.12 19.65
Число акций ао, млн 1 1 1 1.16 1.92 1.97 3.37 6.9 374.39 374.39 77.71 187.08
FCF/акцию -19.05 -25.23 -32.61 -67.6 -41.73 -27.5 -23.78 -14.49 -0.4204 -0.4204 -21.5841 -60.13


Efficiency

IFRS
Reporting Annual Quarterly
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 LTM Industry average 5 year average CAGR 5
ROE, % -34.46 -54.11 -65.77 -138.5 -80.93 -58.81 -124.87 -289.17 -59.28 -59.28 17.60 -122.6120 -6.04
ROA, % -32.35 -48.57 -57.05 -100.04 -66.09 -48.46 -92.58 -164.06 -43.78 -43.78 5.71 -82.9940 -7.91
ROS, % -468.84 -523.27 -1140.64 -351.14 -3598.75 -38238.15 -23478.33 -23478.33 -23478.33 13.36 -17828.9400 131.76
ROCE, % -54.98 -67.42 -123.93 -56.13 -73.12 -150.79 -78.43 -23.23 -24.87 -23.23 9.73 -70.0880 -19.40
Ebit margin, % -350.39 -3657.28 -27431.94 -14535.44 -14535.44 -14535.44 -12102.0980 110.66
Рентаб EBITDA, % -470.48 -526.94 -1161.78 -341.92 -3572.95 -27347.97 -23472.57 -23472.57 -23472.57 26.54 -15641.5960 132.98
Чистая рентаб, % -468.84 -523.27 -1140.64 -351.14 -3598.75 -38238.15 -23478.33 -23478.33 13.36 -13361.4020 83.11
Operation Margin, % -473.34 -531.72 -1169.32 -350.33 -3640.23 -27347.97 -23540.18 -23540.18 -23540.18 16.64 -15683.7780 131.99
Доходность FCF, % -301 -509.55 -373.13 -870.32 -531.36 -389.79 -2069.28 -141.15 -800.3800 -30.50


Coefficients

IFRS
Reporting Annual Quarterly
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 LTM Industry average 5 year average CAGR 5
P/E
-0.2917 -0.1818 -0.1971 -0.0986 -0.1862 -0.2117 -0.0462 -0.2089 64.96 -0.1503 16.20
P/BV
0.1005 0.0984 0.1296 3.72 2.7 2.79 0.6015 0.681 16.3 16.3 8.15 4.61 43.27
P/S
1.37 0.9514 2.25 12.51 12.99 141.44 9524.47 9524.47 7.50 1938.73 431.29
P/FCF
-0.1963 -0.268 -0.1149 -0.1882 -0.2565 -0.0483 -0.7085 0 0 0 8.97 -0.2633 43.88
E/P
-5.5 -5.07 -10.14 -5.37 -4.72 -21.63 -4.79 0 0 0 0.03 -9.3300 -13.93
EV/EBIT
-2.88 -4.15 -4.6 -0.000268 -0.0863 -64.83 -66.98 -64.83 -27.2993 70.86
EV/EBITDA
-2.92 -4.17 -4.72 -0.000274 -0.0866 -40.15 -40.15 51.61 -9.8254 57.29
EV/S
16.13 0.0098 23.68 9423.54 9736.24 9423.54 7.82 3839.92 259.87
EV/FCF
-3.45 -4.19 -5.57 -0.000284 -0.21 -53.04 -54.8 -53.04 17.75 -22.7241 57.97
Debt/EBITDA
-0.0645 -0.0677 -0.079 -0.0556 -0.349 -0.4066 -0.4066 -0.4066 2.58 -0.2594 38.77
Netdebt/Ebitda
0.4673 0.4973 0.1779 1.05 0.1574 0.3633 0.4306 0.43 0.43 0.43 0.46 0.3623 22.26
Debt/Ratio
0.0616 0.0337 0.046 0.0651 0.2473 0.139 0.139 0.139 0.24 0.1273 24.75
Debt/Equity
0.0853 0.039 0.0603 0.092 0.4595 0.1633 0.1751 0.1633 1.91 0.1900 23.76
Debt/Net Income
-0.0655 -0.0673 -0.0769 -0.0552 -0.2496 -0.4065 -0.4065 -0.4065 10.75 -0.2389 39.52
PEG
0 0
Бета
-1.6 0.0579 0.0579 -0.19 -0.7711 -119.02
Индекс Альтмана
-2.15 -0.9071 -0.9071 12.59 -1.5286 -35.05


Dividends

IFRS
Reporting Annual
LTM Industry average 5 year average CAGR 5
Дивиденд
0
Див доход, ао, %
0 1.71


Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription

Subscribe

Other

IFRS
Reporting Annual
2021 2022 2024 CAGR 5
CAPEX/Выручка, %
3.06 1.63 -27.02
Персонал, чел
30 0.00